Correvio Pharma Corp. Increase (Decrease) in Receivables
Correvio Pharma Corp. reported Increase (Decrease) in Receivables of $4.08 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2020-04-30
| Period end | Increase (Decrease) in Receivables 12 month | Increase (Decrease) in Receivables 12 month as first filed |
|---|---|---|
| 2019-12-31 | $4.08M 20-F · filed 2020-04-30 | |
| 2018-12-31 | $2.04M 20-F · filed 2020-04-30 | |
| 2017-12-31 | -$448.00K 20-F · filed 2020-04-30 | |
| 2016-12-31 | -$506.00K 20-F · filed 2018-04-30 | |
| 2015-12-31 | -$3.07M 20-F · filed 2018-04-30 | |
| 2014-12-31 | $3.50M 40-F · filed 2016-03-29 | |
| 2013-12-31 | -$448.00K 40-F · filed 2015-03-27 | |
| 2012-12-31 | -$270.00K 40-F/A · filed 2014-04-30 | |
| 2011-12-31 | $506.00K 20-F/A · filed 2013-04-18 | -$506.00K 40-F/A · filed 2012-04-25 |
| 2010-12-31 | -$711.00K 20-F/A · filed 2013-04-18 | $711.00K 40-F/A · filed 2012-04-25 |